logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Lamport-went, Steven James
    Born in April 1964
    Individual (8 offsprings)
    Officer
    icon of calendar 2008-03-20 ~ now
    OF - Director → CIF 0
    Lamport-went, Steven James
    Director
    Individual (8 offsprings)
    Officer
    icon of calendar 2008-03-20 ~ now
    OF - Secretary → CIF 0
  • 2
    Mcananey, Stephen Peter
    Born in June 1979
    Individual (4 offsprings)
    Officer
    icon of calendar 2008-03-20 ~ now
    OF - Director → CIF 0
  • 3
    Al-tarafi, Issam Adil
    Born in May 1975
    Individual (7 offsprings)
    Officer
    icon of calendar 2008-03-20 ~ now
    OF - Director → CIF 0
  • 4
    icon of addressMoor Place, 1 Fore Street Avenue, Fore Street Avenue, London, United Kingdom
    Active Corporate (3 parents, 3 offsprings)
    Equity (Company account)
    232,185 GBP2024-12-31
    Person with significant control
    icon of calendar 2018-03-07 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 6
  • 1
    Buhagiar, Bryan
    Individual
    Officer
    icon of calendar 2008-03-20 ~ 2008-03-20
    OF - Secretary → CIF 0
  • 2
    Buhagiar, Susan
    Director born in June 1960
    Individual (3 offsprings)
    Officer
    icon of calendar 2008-03-20 ~ 2008-03-20
    OF - Director → CIF 0
  • 3
    Stephen Peter Mcananey
    Born in June 1979
    Individual (4 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2020-02-26
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 4
    Lynam, Colin John
    Company Director born in December 1982
    Individual (1 offspring)
    Officer
    icon of calendar 2010-12-16 ~ 2025-01-31
    OF - Director → CIF 0
  • 5
    DE FACTO CONSULTING LIMITED - 2004-06-03
    icon of addressThe Warehouse, 212 New King’s Road, London, United Kingdom
    Active Corporate (3 parents, 3 offsprings)
    Equity (Company account)
    1,574,525 GBP2023-12-31
    Person with significant control
    2016-04-06 ~ 2018-03-07
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
  • 6
    icon of addressThe Warehouse 212, New King's Road, London, United Kingdom
    Active Corporate (3 parents, 1 offspring)
    Equity (Company account)
    3,000 GBP2023-12-31
    Person with significant control
    2018-03-07 ~ 2018-03-07
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
parent relation
Company in focus

I-PHARM CONSULTING LIMITED

Standard Industrial Classification
78109 - Other Activities Of Employment Placement Agencies
Brief company account
Par Value of Share
Class 1 ordinary share
02024-01-01 ~ 2024-12-31
Turnover/Revenue
9,321,448 GBP2024-01-01 ~ 2024-12-31
16,101,550 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
7,077,202 GBP2024-01-01 ~ 2024-12-31
12,495,421 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
2,244,246 GBP2024-01-01 ~ 2024-12-31
3,606,129 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
4,160,464 GBP2024-01-01 ~ 2024-12-31
3,166,667 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
-204,638 GBP2024-01-01 ~ 2024-12-31
868,152 GBP2023-01-01 ~ 2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
12,443 GBP2024-01-01 ~ 2024-12-31
Interest Payable/Similar Charges (Finance Costs)
13 GBP2024-01-01 ~ 2024-12-31
78,506 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
-192,208 GBP2024-01-01 ~ 2024-12-31
789,646 GBP2023-01-01 ~ 2023-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-42,687 GBP2024-01-01 ~ 2024-12-31
197,074 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-149,521 GBP2024-01-01 ~ 2024-12-31
592,572 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
11,834 GBP2024-01-01 ~ 2024-12-31
592,572 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
3,353 GBP2024-12-31
9,206 GBP2023-12-31
Fixed Assets
3,353 GBP2024-12-31
9,206 GBP2023-12-31
Debtors
2,749,734 GBP2024-12-31
6,123,102 GBP2023-12-31
Cash at bank and in hand
1,443,651 GBP2024-12-31
256,609 GBP2023-12-31
Current Assets
4,193,385 GBP2024-12-31
6,379,711 GBP2023-12-31
Creditors
Current
568,160 GBP2024-12-31
2,379,723 GBP2023-12-31
Net Current Assets/Liabilities
3,625,225 GBP2024-12-31
3,999,988 GBP2023-12-31
Total Assets Less Current Liabilities
3,628,578 GBP2024-12-31
4,009,194 GBP2023-12-31
Equity
Called up share capital
114 GBP2024-12-31
114 GBP2023-12-31
Share premium
207,474 GBP2024-12-31
207,474 GBP2023-12-31
207,474 GBP2022-12-31
Retained earnings (accumulated losses)
3,259,635 GBP2024-12-31
3,801,606 GBP2023-12-31
3,699,034 GBP2022-12-31
Equity
3,628,578 GBP2024-12-31
4,009,194 GBP2023-12-31
3,906,508 GBP2022-12-31
Issue of Equity Instruments
Called up share capital
114 GBP2023-01-01 ~ 2023-12-31
Issue of Equity Instruments
114 GBP2023-01-01 ~ 2023-12-31
Dividends Paid
Retained earnings (accumulated losses)
-392,450 GBP2024-01-01 ~ 2024-12-31
-490,000 GBP2023-01-01 ~ 2023-12-31
Dividends Paid
-392,450 GBP2024-01-01 ~ 2024-12-31
-490,000 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-149,521 GBP2024-01-01 ~ 2024-12-31
592,572 GBP2023-01-01 ~ 2023-12-31
Wages/Salaries
2,374,473 GBP2024-01-01 ~ 2024-12-31
1,937,238 GBP2023-01-01 ~ 2023-12-31
Social Security Costs
229,604 GBP2024-01-01 ~ 2024-12-31
170,562 GBP2023-01-01 ~ 2023-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
53,027 GBP2024-01-01 ~ 2024-12-31
19,061 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
2,657,104 GBP2024-01-01 ~ 2024-12-31
2,126,861 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
352024-01-01 ~ 2024-12-31
502023-01-01 ~ 2023-12-31
Director Remuneration
24,000 GBP2024-01-01 ~ 2024-12-31
77,318 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
7,639 GBP2024-01-01 ~ 2024-12-31
10,160 GBP2023-01-01 ~ 2023-12-31
Audit Fees/Expenses
9,000 GBP2024-01-01 ~ 2024-12-31
18,015 GBP2023-01-01 ~ 2023-12-31
Current Tax for the Period
188,104 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
-48,052 GBP2024-01-01 ~ 2024-12-31
185,725 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Land and buildings, Short leasehold
1,140 GBP2024-12-31
1,140 GBP2023-12-31
Furniture and fittings
610 GBP2024-12-31
610 GBP2023-12-31
Computers
43,315 GBP2024-12-31
41,529 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
45,065 GBP2024-12-31
43,279 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Short leasehold
792 GBP2024-12-31
412 GBP2023-12-31
Furniture and fittings
610 GBP2024-12-31
610 GBP2023-12-31
Computers
40,310 GBP2024-12-31
33,051 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
41,712 GBP2024-12-31
34,073 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings, Short leasehold
380 GBP2024-01-01 ~ 2024-12-31
Computers
7,259 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
7,639 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Land and buildings, Short leasehold
348 GBP2024-12-31
Computers
3,005 GBP2024-12-31
8,478 GBP2023-12-31
Investments in Group Undertakings
Cost valuation
207,551 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
1,314,950 GBP2024-12-31
3,073,609 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
1,243,263 GBP2024-12-31
2,930,041 GBP2023-12-31
Other Debtors
Current
83,139 GBP2024-12-31
Amount of value-added tax that is recoverable
Current
3,026 GBP2024-12-31
Debtors - Deferred Tax Asset
Current
42,687 GBP2024-12-31
Prepayments/Accrued Income
Current
12,000 GBP2024-12-31
Prepayments
Current
50,669 GBP2024-12-31
119,452 GBP2023-12-31
Debtors
Amounts falling due within one year, Current
2,749,734 GBP2024-12-31
6,123,102 GBP2023-12-31
Trade Creditors/Trade Payables
Current
275,427 GBP2024-12-31
967,306 GBP2023-12-31
Amounts owed to group undertakings
Current
90,193 GBP2024-12-31
234,423 GBP2023-12-31
Corporation Tax Payable
Current
-110,001 GBP2024-12-31
78,103 GBP2023-12-31
Other Taxation & Social Security Payable
Current
38,441 GBP2024-12-31
108,146 GBP2023-12-31
Other Creditors
Current
48,347 GBP2024-12-31
650,613 GBP2023-12-31
Accrued Liabilities
Current
225,753 GBP2024-12-31
300,527 GBP2023-12-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
-42,687 GBP2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,143,214 shares2024-12-31

Related profiles found in government register
  • I-PHARM CONSULTING LIMITED
    Info
    Registered number 06540985
    icon of addressMoor Place, 1 Fore Street Avenue, London EC2Y 9DT
    PRIVATE LIMITED COMPANY incorporated on 2008-03-20 (17 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2025-03-20
    CIF 0
  • I-PHARM CONSULTING LIMITED
    S
    Registered number 06540985
    icon of address3rd Floor, 22 Long Acre, London, United Kingdom, WC2E 9LY
    CIF 1 CIF 2
  • I-PHARM CONSULTING LIMITED
    S
    Registered number 06540985
    icon of addressMoor Place, 1 Fore Street Avenue, Fore Street Avenue, London, United Kingdom, EC2Y 9DT
    Limited By Shares in Companies House, United Kingdom
    CIF 3
child relation
Offspring entities and appointments
Active 3
  • 1
    icon of addressParcels Building, 14 Bird Street, London, United Kingdom
    Active Corporate (53 parents)
    Profit/Loss (Company account)
    390,655 GBP2024-01-01 ~ 2024-12-31
    Officer
    icon of calendar 2011-12-02 ~ now
    CIF 2 - LLP Member → ME
  • 2
    icon of addressParcels Building, 14 Bird Street, London, United Kingdom
    Active Corporate (32 parents)
    Officer
    icon of calendar 2012-12-19 ~ now
    CIF 1 - LLP Member → ME
  • 3
    icon of addressMoor Place 1 Fore Street Avenue, Fore Street Avenue, London, United Kingdom
    Active Corporate (4 parents)
    Equity (Company account)
    100 GBP2024-12-31
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    CIF 3 - Right to appoint or remove directorsOE
    CIF 3 - Ownership of shares – 75% or moreOE
    CIF 3 - Ownership of voting rights - 75% or moreOE

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.